SIA
TMO icon

Soltis Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Soltis Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Sell
3,495
-108
-3% -$51.8K 0.1% 173
2026
Q1 		$1.77M Sell
3,603
-25
-0.7% -$13.6K 0.11% 157
2025
Q4 		$2.1M Buy
3,628
+2,031
+127% +$1.15M 0.14% 138
2025
Q3 		$775K Buy
1,597
+178
+13% +$82.9K 0.05% 234
2025
Q2 		$575K Sell
1,419
-7,113
-83% -$2.97M 0.05% 241
2025
Q1 		$4.25M Buy
8,532
+906
+12% +$491K 0.38% 75
2024
Q4 		$3.97M Buy
7,626
+6,366
+505% +$3.5M 0.37% 77
2024
Q3 		$779K Buy
1,260
+4
+0.3% +$2.37K 0.08% 173
2024
Q2 		$695K Sell
1,256
-81
-6% -$46.4K 0.07% 176
2024
Q1 		$777K Sell
1,337
-955
-42% -$536K 0.09% 159
2023
Q4 		$1.22M Sell
2,292
-1,143
-33% -$553K 0.14% 132
2023
Q3 		$1.74M Sell
3,435
-1,298
-27% -$692K 0.22% 114
2023
Q2 		$2.47M Sell
4,733
-25
-0.5% -$13.5K 0.29% 94
2023
Q1 		$2.74M Sell
4,758
-1,622
-25% -$914K 0.35% 87
2022
Q4 		$3.51M Buy
6,380
+2,043
+47% +$1.08M 0.46% 64
2022
Q3 		$2.2M Buy
4,337
+48
+1% +$26.9K 0.33% 79
2022
Q2 		$2.33M Sell
4,289
-32
-0.7% -$17.6K 0.34% 74
2022
Q1 		$2.55M Buy
4,321
+40
+0.9% +$23K 0.35% 70
2021
Q4 		$2.86M Buy
4,281
+1,123
+36% +$701K 0.4% 53
2021
Q3 		$1.8M Sell
3,158
-2,305
-42% -$1.27M 0.28% 76
2021
Q2 		$2.76M Buy
5,463
+911
+20% +$430K 0.44% 42
2021
Q1 		$2.08M Buy
4,552
+711
+19% +$339K 0.38% 50
2020
Q4 		$1.79M Buy
3,841
+2,876
+298% +$1.35M 0.33% 51
2020
Q3 		$426K Sell
965
-4
-0.4% -$1.65K 0.1% 135
2020
Q2 		$351K Buy
969
+7
+0.7% +$2.35K 0.09% 141
2020
Q1 		$273K Hold
962
– – 0.08% 130
2019
Q4 		$313K Buy
+962
New +$292K 0.06% 117

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Soltis Investment Advisors's TMO Position: Q2 2026 in Review

Soltis Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 3% in Q2 2026, selling an estimated $51.8K and leaving 3,495 shares worth $1.75M. The position accounts for 0.1% of the portfolio, ranked #173.

Soltis Investment Advisors first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.25M in Q1 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Soltis Investment Advisors held 3,495 shares of Thermo Fisher Scientific worth $1.75M as of Q2 2026.
  • Soltis Investment Advisors sold 108 Thermo Fisher Scientific shares in Q2 2026, an estimated $51.8K.
  • Thermo Fisher Scientific made up 0.1% of Soltis Investment Advisors's portfolio in Q2 2026, its #173 holding.
  • Soltis Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Soltis Investment Advisors's Thermo Fisher Scientific position peaked at $4.25M in Q1 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.